FIELD: biotechnology.
SUBSTANCE: invention relates to a method for improving the contractility of the heart, increasing the capillary density, or reducing myocardial hypertrophy in a patient with a damaged myocardium, which can be used in medicine. This method includes an administration of a purified cell pool, derived from cardial tissue of a human, where these cells do not express telomerase, heavy chain of myosin, CD31, CD45 and CD16 and express GATA4, Nkx2.5, CD105, CD90, CD59 and CD54.
EFFECT: invention allows you to effectively improve the contractility of the heart, increase capillary density or reduce myocardial hypertrophy in patients after acute myocardial infarction.
16 cl, 39 dwg, 30 tbl, 20 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CELLS DERIVED FROM CARDIAC TISSUE | 2010 |
|
RU2662675C1 |
| CELLS BEING DERIVATIVES OF CARDIAC TISSUE | 2010 |
|
RU2583287C2 |
| PHARMACEUTICAL PREPARATION | 2009 |
|
RU2542512C2 |
| COMPOSITIONS IMPROVING MYOCARDIAL INFARCTION PERFUSION AND METHODS FOR REGENERATION AFTER VASCULAR INJURY | 2013 |
|
RU2550959C2 |
| METHOD FOR OBTAINING AND APPLICATION OF TISSUE ENGINEERING STRUCTURES BASED ON PROGENITAL CELLS FOR HEART DISEASES TREATMENT | 2015 |
|
RU2636464C2 |
| BIOTRANSPLANT AND METHOD FOR TREATING CHRONIC CARDIAC FAILURE (VARIANTS) | 2005 |
|
RU2299073C1 |
| BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING ISCHEMIC CARDIAC DISEASE | 2004 |
|
RU2268061C1 |
| METHOD FOR PREPARATION AND INDUCTION OF DIRECTIONAL DIFFERENTIATION OF MULTIPOTENT CARDIAC CELL CULTURE FOR CELL-BASED THERAPY AND/OR TISSUE ENGINEERING WITHIN MYOCARDIAL ISCHEMIA | 2008 |
|
RU2366706C1 |
| APPLICATION OF COMPOSITION CONSISTING OF CONCENTRATED CELL POPULATION REPRESENTING STEM CELLS AND UNDIFFERENTIATED PRECURSORS | 2004 |
|
RU2372924C2 |
| METHOD FOR CARDIO-GENERATIVE POTENTIAL DETERMINATION IN MAMMAL CELLS | 2010 |
|
RU2624498C2 |
